Composition and methods for the treatment of myopia
US11285141B2 · kind B2 · utility
1Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2018 |
| Grant date | Mar 29, 2022 |
| Priority date | — |
| Expiry date | Sep 24, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods useful in slowing, inhibiting, or regressing the progression of myopia, while minimizing pupil dilation and light sensitivity are provided herein. Provided compositions can include a muscarinic receptor antagonist and a miotic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.